Obesity in Classic Congenital Adrenal Hyperplasia: Mechanisms, Complications and Management
ABSTRACT Classic congenital adrenal hyperplasia (CCAH) is an autosomal recessive genetic disorder primarily caused by 21‐hydroxylase deficiency. Although the survival rate of patients has significantly improved with glucocorticoid replacement therapy, long‐term use of supraphysiological doses and multiple factors inherent to the disease itself have led
Jialin Mu +5 more
wiley +1 more source
Prenatal exposure to the mineralocorticoid receptor antagonist spironolactone disrupts hippocampal area CA2 connectivity and alters behavior in mice. [PDF]
Jones SM +5 more
europepmc +1 more source
ABSTRACT Aims This prespecified analysis evaluated whether the safety and efficacy of finerenone and a sodium–glucose cotransporter 2 inhibitor (SGLT2i) combination vary by baseline glycated haemoglobin (HbA1c). Materials and Methods Adults with type 2 diabetes and a urinary albumin‐to‐creatinine ratio (UACR) of 100 − < 5000 mg/g, estimated glomerular ...
Janet B. McGill +15 more
wiley +1 more source
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Ocedurenone (KBP-5074) in Individuals with Moderate Hepatic Impairment. [PDF]
McCabe J, Zhang J, Yang F, Benn V.
europepmc +1 more source
This graphical abstract summarizes 716 patients with acute heart failure and atrial fibrillation. The left atrial diameter analysis included 691 patients (189 rehospitalization‐first, 118 death‐first, 384 censored); volume index and reservoir strain were available in a 320‐patient single‐center subgroup.
Jumpei Yamamoto +7 more
wiley +1 more source
Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death. [PDF]
Hedlund Møller S +6 more
europepmc +1 more source
Higher NYHA class was associated with greater comorbidity burden and worse cardiac structure and function at baseline in patients with acute heart failure. Despite these differences, echocardiographic abnormalities improved at follow‐up, and 180‐day mortality or readmission did not differ significantly across NYHA classes.
Ali Hikmat Al‐Rubai +23 more
wiley +1 more source
Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial. [PDF]
Cherney DZI +10 more
europepmc +1 more source
Among 560 predominantly older patients discharged after acute heart failure with atrial fibrillation, withholding oral anticoagulation was associated with higher ischemic stroke and did not indicate lower bleeding risk. Bleeding risk was significantly higher among patients aged 80 years or older.
Jumpei Yamamoto +7 more
wiley +1 more source
ABSTRACT Mineralocorticoid receptor antagonists (MRAs), aldosterone synthase inhibitors (ASIs), and epithelial sodium channel (ENaC) blockade target different levels of the aldosterone‐related sodium‐retention pathway in resistant hypertension (RH), but the comparative efficacy of individual agents remains uncertain.
Yi‐Liang Tsou +3 more
wiley +1 more source

